Abstract:The main mol-ecule of the title solvate, C(33)H(30)N(2)O(10)·CH(3)OH, is a new anti-tumor agent, which shows cytotoxicity against MDR cancer cell lines. It has been synthesized by coupling 4β-amino-podophyllotoxin with (5-meth-oxy-1H-indol-3-yl)glyoxyl chloride and structurally characterized. There are two crystallographically independent mol-ecules in the asymmetric unit, which differ in the dihedral angles between the aromatic rings. The dihedral angles between the benzene ring of the benzo[d][1,3]dioxole and the benzene ring of the 5-meth-oxy-1H-indole are 85.08 (3) and 76.88 (3)° and reflect the main conformational difference between the two independent mol-ecules. The asymmetric unit is completed with two methanol solvent mol-ecules, one of which is disordered over two positions, with occupancies close to 0.5.

(5R,5ar,8ar,9s)-5-(3,4-dihydroxy-5-methoxyphenyl)-9-fluoro-5,8,8a,9-tetrahydrofuro[3′,4′:6,7]Naphtho[2,3-d]-1,3-dioxol-6(5ah)-one Acetone Solvate

(5Ar,8ar,9r)-9-(3,4,5-trimethoxyphenyl)5a,6,8a,9-tetrahydrofuro[3 ',4 ': 6,7]Naphtho[2,3-D][1,3]dioxole-5,8-dione

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

4-Des-oxy-4β-[(5-meth-oxy-1H-indol-3-yl)oxalylamino]podophyllotoxin methanol solvate.

10-Hexyl-10h-phenothiazine-3-carbaldehyde

Dimethyl 2-(4-Fluorophenyl)-3-(methylamino)-furan-4,5-dicarboxylate

4,5-Diazafluoren-9-ol

1-(4-Fluoro-phen-yl)-3-hydr-oxy-3-phenyl-prop-2-en-1-one.

5,5′-Dimethyl-4,4′-(3,3,4,4,5,5-hexafluorocyclopentene-1,2-diyl)bis(thiophene-2-carboxylic Acid) Acetone 0.25-Solvate

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

1,5-Bis[(2-meth-oxy-eth-oxy)meth-yl]-1,5-naphthyridine-4,8(1H,5H)-dione.

(E)-Dimethyl 4-(Ethylamino)-5-styrylfuran-2,3-dicarboxylate

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

1,5-Bis[(2-methoxyethoxy)methyl]-1,5-naphthyridine-4,8(1H,5H)-dione

(4′S)-4′-Ethyl-3′,10′-dioxo-3′,4′, 7′,8′-tetrahydrospiro-[1,3-dioxolane-2,6′-1′H, 6′H-pyrano[3,4-f]indolizin]-4′-yl N-(1-phenylethyl)carbamate

Fluorenonophane chloro-benzene solvate: mol-ecular and crystal structures

1,2,3,5A,6,11,12,14a-Octahydro-9-methoxy-12-(2-methylprop-1-enyl)-5h,14h-pyrrolo[1′′,2′′:4′,5′]Pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-5,14-dione

3,4-O-isopropylidene-2,7-di-o-p-tolylsulfonyl-α-l-xylo-3-heptulo-3,6-furanosononitrile

2-(4-Fluorophenoxy)-n-methylacetamide

(5Α,8α,9β,11s)-5,7,8,9-tetrahydro-11-(fluoromethyl)-9-(3,4,5-trimethoxyphenyl)-5,8-methano-1,3-dioxolo[4,5-h][2]benzoxepin